Literature DB >> 26490460

Moderate inhibition of mitochondrial function augments carotid body hypoxic sensitivity.

Andrew P Holmes1, Philip J Turner2, Keith J Buckler2, Prem Kumar3.   

Abstract

A functional role for the mitochondria in acute O2 sensing in the carotid body (CB) remains undetermined. Whilst total inhibition of mitochondrial activity causes intense CB stimulation, it is unclear whether this response can be moderated such that graded impairment of oxidative phosphorylation might be a mechanism that sets and modifies the O2 sensitivity of the whole organ. We assessed NADH autofluorescence and [Ca2+]i in freshly dissociated CB type I cells and sensory chemoafferent discharge frequency in an intact CB preparation, in the presence of varying concentrations of nitrite (NO2 −), a mitochondrial nitric oxide (NO) donor and a competitive inhibitor of mitochondrial complex IV. NO2 − increased CB type I cell NADH in a manner that was dose-dependent and rapidly reversible. Similar concentrations of NO2 − raised type I cell [Ca2+]i via L-type channels in a PO2-dependent manner and increased chemoafferent discharge frequency. Moderate inhibition of the CB mitochondria by NO2 − augmented chemoafferent discharge frequency during graded hypoxia, consistent with a heightened CB O2 sensitivity. Furthermore, NO2 − also exaggerated chemoafferent excitation during hypercapnia signifying an increase in CB CO2 sensitivity. These data show that NO2 − can moderate the hypoxia sensitivity of the CB and thus suggest that O2 sensitivity could be set and modified in this organ by interactions between NO and mitochondrial complex IV.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26490460     DOI: 10.1007/s00424-015-1745-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  55 in total

1.  Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes.

Authors:  Pablo R Castello; Pamela S David; Travis McClure; Zachary Crook; Robert O Poyton
Journal:  Cell Metab       Date:  2006-04       Impact factor: 27.287

2.  Type I cell ROS kinetics under hypoxia in the intact mouse carotid body ex vivo: a FRET-based study.

Authors:  A Bernardini; U Brockmeier; E Metzen; U Berchner-Pfannschmidt; E Harde; A Acker-Palmer; D Papkovsky; H Acker; J Fandrey
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-15       Impact factor: 4.249

Review 3.  Role of the carotid body in the pathophysiology of heart failure.

Authors:  Harold D Schultz; Noah J Marcus; Rodrigo Del Rio
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

4.  Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.

Authors:  P K Chatterjee; S Cuzzocrea; P A Brown; K Zacharowski; K N Stewart; H Mota-Filipe; C Thiemermann
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

5.  Nitrite reductase activity is a novel function of mammalian mitochondria.

Authors:  A V Kozlov; K Staniek; H Nohl
Journal:  FEBS Lett       Date:  1999-07-02       Impact factor: 4.124

6.  NADPH oxidase-derived superoxide anion mediates angiotensin II-enhanced carotid body chemoreceptor sensitivity in heart failure rabbits.

Authors:  Yu-Long Li; Lie Gao; Irving H Zucker; Harold D Schultz
Journal:  Cardiovasc Res       Date:  2007-04-19       Impact factor: 10.787

Review 7.  Mitochondria as metabolizers and targets of nitrite.

Authors:  Sruti Shiva
Journal:  Nitric Oxide       Date:  2009-09-27       Impact factor: 4.427

8.  Relative mitochondrial membrane potential and [Ca2+]i in type I cells isolated from the rabbit carotid body.

Authors:  M R Duchen; T J Biscoe
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

9.  Postnatal development of CO2-O2 interaction in the rat carotid body in vitro.

Authors:  D R Pepper; R C Landauer; P Kumar
Journal:  J Physiol       Date:  1995-06-01       Impact factor: 5.182

10.  Extracellular potassium and chemosensitivity in the rat carotid body, in vitro.

Authors:  D R Pepper; R C Landauer; P Kumar
Journal:  J Physiol       Date:  1996-06-15       Impact factor: 5.182

View more
  6 in total

Review 1.  Acute oxygen sensing by the carotid body: a rattlebag of molecular mechanisms.

Authors:  Ryan J Rakoczy; Christopher N Wyatt
Journal:  J Physiol       Date:  2017-12-27       Impact factor: 5.182

Review 2.  Are Multiple Mitochondrial Related Signalling Pathways Involved in Carotid Body Oxygen Sensing?

Authors:  Andrew P Holmes; Agnieszka Swiderska; Demitris Nathanael; Hayyaf S Aldossary; Clare J Ray; Andrew M Coney; Prem Kumar
Journal:  Front Physiol       Date:  2022-05-31       Impact factor: 4.755

3.  Ecto-5'-nucleotidase (CD73) regulates peripheral chemoreceptor activity and cardiorespiratory responses to hypoxia.

Authors:  Andrew P Holmes; Clare J Ray; Selina A Pearson; Andrew M Coney; Prem Kumar
Journal:  J Physiol       Date:  2017-07-09       Impact factor: 5.182

Review 4.  G-Protein-Coupled Receptor (GPCR) Signaling in the Carotid Body: Roles in Hypoxia and Cardiovascular and Respiratory Disease.

Authors:  Hayyaf S Aldossary; Abdulaziz A Alzahrani; Demitris Nathanael; Eyas A Alhuthail; Clare J Ray; Nikolaos Batis; Prem Kumar; Andrew M Coney; Andrew P Holmes
Journal:  Int J Mol Sci       Date:  2020-08-20       Impact factor: 5.923

Review 5.  Is Carotid Body Physiological O2 Sensitivity Determined by a Unique Mitochondrial Phenotype?

Authors:  Andrew P Holmes; Clare J Ray; Andrew M Coney; Prem Kumar
Journal:  Front Physiol       Date:  2018-05-16       Impact factor: 4.566

6.  β-Adrenoceptor blockade prevents carotid body hyperactivity and elevated vascular sympathetic nerve density induced by chronic intermittent hypoxia.

Authors:  Abdulaziz A Alzahrani; Lily L Cao; Hayyaf S Aldossary; Demitris Nathanael; Jiarong Fu; Clare J Ray; Keith L Brain; Prem Kumar; Andrew M Coney; Andrew P Holmes
Journal:  Pflugers Arch       Date:  2020-11-19       Impact factor: 3.657

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.